Videos de Experimentos Relacionados
La pancreatitis aguda es una pancreatitis aguda.
C Fernández-del Castillo1, D W Rattner, A L Warshaw
1Department of Surgery, Massachusetts General Hospital, Boston 02114.
Lancet (London, England)
|August 21, 1993
Resumen
No abstract available in PubMed .
Videos de Conceptos Relacionados
También podría leer
Artículos Relacionados
Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.
Ordenar por
Same author
Influence of Klebsiella pneumoniae and quinolone treatment on prognosis in patients with pancreatic cancer.
The British journal of surgery·2021
Same author
Preoperative cholangitis is an independent risk factor for mortality in patients after pancreatoduodenectomy for pancreatic cancer.
American journal of surgery·2020
Same author
Risk of malignancy in small pancreatic cysts decreases over time.
Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]·2020
Same author
An elevated CA 19-9 is associated with invasive cancer and worse survival in IPMN.
Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]·2020
Same author
International consensus guidelines for surgery and the timing of intervention in chronic pancreatitis.
Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]·2019
Same author
Intraoperative Fluid Administration and Surgical Outcomes Following Pancreaticoduodenectomy: External Validation at a Tertiary Referral Center.
World journal of surgery·2018
Same journal
Assisted dying and the silencing of medicine's next generation.
Lancet (London, England)·2026
Same journal
Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.
Lancet (London, England)·2026
Same journal
Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.
Lancet (London, England)·2026
Same journal
[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.
Lancet (London, England)·2026
Same journal
Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.
Lancet (London, England)·2026